"Iridina", drops for eyes: instruction manual, analogues, reviews

Reddened sclera of the eyes - not the most pleasant phenomenon, which can result from lack of sleep, overwork, excessive strain on the organs of vision. Regardless of the cause of this condition, it gives the person a tired, broken look and delivers a lot of discomfort.

The redness of the sclera may look different. In some cases, the enlarged vessels are seen on the eye proteins, while in others the sclera acquires a uniform pink tint (in situations where small capillaries are involved).

Vascular dilation occurs not only on the so-called eye protein, but also on the mucous membrane of the eyelids - they are also hyperemic and appear swollen.

This deficiency can not be hidden with make-up. Therefore, special ophthalmic agents are a real salvation for owners of tired, reddened eyes. In particular, patients are prescribed the drug "Iridina" - drops for the eyes that have vasoconstrictive action.

Composition

The active active substance is naphazoline hydrochloride. Consequently, any drug having a similar composition, including the widely known "Naphthyzine", is an analogue. "Iridinum" - eye drops, which are positioned as a cosmetic, but in fact are a pharmaceutical drug. Analogues also include the drug Polynadim from the Russian manufacturer.

Operating principle

Reddening of the mucous membrane of the eyes and eyelids is associated with the expansion of small blood capillaries, abundantly localized in the structures of the eyeball. "Whitening" action, which renders the preparation "Iridina" (drops for eyes) is a consequence of the vasoconstrictive effect of the active component.

Nafazoline, which is the active substance of the eye drops "Iridin", belongs to the class of alpha-adrenomimetics. Causing the excitation of alpha-adrenergic receptors, naphazoline hydrochloride provides a vasoconstrictor effect. That is why the redness disappears from the mucous membrane of the eyes.

Indications for use

1. Reddening of the mucosa of the eyeball.
2. Irritation, swelling on the eyelids.
3. Feeling of discomfort in the form of burning eyes or itching.
4. Increased tear production, lacrimation.
5. Increased sensitivity of the eyes to light (both daylight and artificial light).

Before you start using this tool, it is highly advisable to consult an ophthalmologist to clarify the indications and get recommendations on the optimal mode of application of the drug "Iridina". Drops for the eyes are considered safe, but improper use of them can trigger side reactions. Dosage should be made individually.

Preparation "Iridina" (drops for eyes): instructions for use

Drops to eliminate redness is recommended to apply before applying makeup to the eyes. In the conjunctival cavity of each eye, 1-2 drops of the drug are instilled (it is more convenient to do this when lying on the back).

The whitening effect comes in a few minutes and lasts for several hours.

Important! Instillation is allowed no more than three times a day.

Every 5-6 days you need to take a break to avoid getting used to it.

Unwanted adverse reactions

Is the use of the drug "Iridina" safe? Drops for the eyes (instructions and reviews of doctors confirm this) can cause side reactions:

1. Itching, burning, other unpleasant sensations from the mucous membrane of the eye immediately after the instillation of drops.
2. Development of tolerance (resistance) to the action of the drug in the case of prolonged regular use.
3. Often, with frequent prolonged use, the opposite effect is observed: swelling and hyperemia of the mucous membrane of the eyes.
4. Narrowing of the pupil.
5. Actively absorbed when applied topically to the general bloodstream, naphazoline hydrochloride is able to cause a systemic increase in blood pressure.
6. Nausea.
7. Headache.
8. Tachycardia.

Contraindications to the use of drops of "Iridinum"

1. Increased intraocular pressure regardless of etiology (glaucoma and other ophthalmic hypertension).
2. Arterial hypertension (due to the possibility of developing a systemic side effect in the form of an increase in blood pressure). It is highly undesirable to use drugs containing naphazoline, regardless of the origin of this symptom.
3. Diabetes.
4. Hyperthyroidism and thyrotoxicosis.
5. Chronic vasomotor rhinitis (especially if the cause of this disease is the previous use of vasoconstrictor drugs).
6. Patient use of drugs from the group of monoamine oxidase inhibitors (the use of drops can begin not earlier than ten days after the end of the course of taking such drugs).
7. Children's age (drugs containing naphazoline hydrochloride are contraindicated in patients younger than one year old).
8. Infectious-inflammatory processes with localization in the organs of vision.
9. Any cases of intolerance or individual hypersensitivity to the constituent components of the drug in a patient's history.
10. Diseases of the cardiovascular system.
11. There are no data on the excretion of naphazoline hydrochloride with breast milk, therefore it is strongly recommended to refrain from using vasoconstrictors during the breastfeeding period.
12. The drug should not be used to eliminate red eyes in infectious inflammatory diseases of the eyes.

special instructions

1. Vasoconstrictive eye drops should not under any circumstances be replaced by similar nasal drugs, since nasal drops may contain auxiliary ingredients that can adversely affect the structure of the organ of vision. In addition, the concentration of the active substance in the nasal agent is generally higher, which can cause undesirable effects when using such drops as eyeballs.
2. The use of drops during pregnancy is possible only in case of emergency.
3. It should be borne in mind that the action of vasoconstrictive drugs is not constant. With continued systematic use, tolerance to the effect of the drug develops. Avoid this development is possible by taking breaks in the use of drops every few days (once a week or more often).
4. To avoid contamination or infection of the contents of the vial, it is necessary to prevent the tip of the vial from touching the surface of the mucous membrane of the eye during instillation.
5. It is necessary to remember to which group the "Iridina" refers. Drops for the eyes, positioned as a cosmetic, contain a vasoconstrictor component. To avoid the development of side effects from the systematic use of this tool should be avoided.
6. In the case of any ophthalmic diseases, eye drops "Iridina" can be used only after consultation and approval of an ophthalmologist. The doctor will be able to draw up a suitable therapy scheme.
7. In case of appearance on the background of therapy of undesirable side effects or other unusual symptoms, it is necessary to stop using Iridina eye drops. Feedback suggests that side effects occur infrequently, but this situation requires expert advice.

In no case should not engage in self-medication. Remember that improper use of medicines can only exacerbate the situation.